Onyx Biotec Ltd Financials
Company Logo

Onyx Biotec Ltd Financial Statement

Onyx Biotec Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Onyx Biotec Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual61.95
Operating Expenses Annual51.61
Operating Profit Annual11.51
Interest Annual1.99
Depreciation3.05
Net Profit Annual4.95
Tax Annual1.52

Onyx Biotec Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning1.47
Cash Flow from Operations1.42
Cash Flow from Investing0.66
Cash Flow from Financing5.07
Cash Flow at the End8.61

Onyx Biotec Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)17.11
PBIT Margin (%)12.19
PBT Margin (%)6.17
Net PROFIT Margin (%)7.99
Return On Networth / Equity (%)10.43
Return On Networth /Employed (%)12.15
Return On Assets (%)7.99
Total Debt / Equity (X)0.53
Asset Turnover Ratio (%)1

Onyx Biotec Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual40.90
Total Current Assets Annual49.19
Non Current Assets Annual42.06
Total Shareholders Funds Annual55.62
Total Assets Annual91.25

Onyx Biotec Ltd Earning Calls

No Data Availabe

FAQS on Onyx Biotec Ltd Financials

As of Sep 11, 2025, Onyx Biotec Ltd has a market capitalization of 105.17 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Onyx Biotec Ltd is with a debt-to-equity ratio of 0.22.

In FY 2024 , Onyx Biotec Ltd recorded a total revenue of approximately 61.95 Cr marking a significant milestone in the company's financial performance.

Onyx Biotec Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and 0.2% annually, respectively..

Onyx Biotec Ltd's current PE ratio is 21.25.

Onyx Biotec Ltd's ROCE averaged 10.2% from the FY ending March 2023 to 2025, with a median of 11.8%. It peaked at 12.4% in March 2025, reflecting strong capital efficiency over the period..

Onyx Biotec Ltd's latest EBIT is Rs. 8.47 Cr, surpassing the average EBIT of Rs. 6.06 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions